Pharmaceutical innovation and the burden of disease in developing and developed countries

Journal of Medicine and Philosophy 30 (6):663 – 690 (2005)
Abstract I perform two analyses of the relationship across diseases between pharmaceutical innovation and the burden of disease in developed and developing countries. Both analyses indicate that the amount of pharmaceutical innovation is positively related to the burden of disease in developed countries but not to the burden of disease in developing countries. The most plausible explanation for the lack of a relationship between the burden of disease in developing countries and the amount of pharmaceutical innovation is that incentives for firms to develop medicines for diseases primarily afflicting people in developing countries have been weak or nonexistent.
Keywords No keywords specified (fix it)
Categories
Options
 Save to my reading list
Follow the author(s)
My bibliography
Export citation
Find it on Scholar
Edit this record
Mark as duplicate
Revision history Request removal from index
 
Download options
PhilPapers Archive


Upload a copy of this paper     Check publisher's policy on self-archival     Papers currently archived: 5,672
External links
  • Through your library Configure

    Similar books and articles

    Analytics

    Monthly downloads

    Added to index

    2009-01-28

    Total downloads

    7 ( #133,421 of 549,060 )

    Recent downloads (6 months)

    1 ( #63,185 of 549,060 )

    How can I increase my downloads?


    My notes
    Sign in to use this feature


    Discussion
    Start a new thread
    Order:
    There  are no threads in this forum
    Nothing in this forum yet.

    Other forums